Treatment and prevention of hepatitis B and C in thalassemia

Hemoglobin

Volumn 33, Issue SUPPL. 1, 2009, Pages

  Mallat, Michella E ^a   Sharara, Ala I ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Hepatitis B; Hepatitis C; Interferon; Nucleos(t)ide analogues; Thalassemia

Indexed keywords

ADEFOVIR; ENTECAVIR; HEPATITIS B VACCINE; HEPATITIS C VACCINE; LAMIVUDINE; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN; TELBIVUDINE; TENOFOVIR;

CONFERENCE PAPER; DISEASE COURSE; HEMOLYSIS; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; MONOTHERAPY; POLYMERASE CHAIN REACTION; THALASSEMIA; VACCINATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANTIVIRAL AGENTS; BLOOD TRANSFUSION; HEMOLYSIS; HEPATITIS B; HEPATITIS C; HUMANS; RIBAVIRIN; THALASSEMIA;

HEPATITIS C VIRUS;

EID: 73949132431     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.3109/03630260903351437     Document Type: Conference Paper

References (15)

1. Hofer H, Watkins-Riedel T, Janata O, et al. Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load. Hepatology. 2003;37(1):60-64. (Pubitemid 36042145)
2. Pimstone NR, Pimstone D, Saicheur T, et al. 'Wait-and-see': An alternative approach to managing acute hepatitis C with high-dose interferon-alpha monotherapy. Ann Intern Med. 2004;141(6): W91-W92.
3. Cunningham MJ, Macklin EA, Neufeld EJ, et al. Complications of beta-thalassemia major in North America. Blood. 2004;104(1):34-39.
4. Jaeckel E, Cornberg M, Wedemeyer H, et al. Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med. 2001;345(20):1452-1457.
5. Kamal SM, Fouly AE, Kamel RR, et al. Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response. Gastroenterology. 2006;130(3):632-638.
6. Sharara AI, Aoun E, Koussa S, et al. Treatment of acute hepatitis C in a child with thalassemia major using weight-based peginterferon alpha-2b. J Gastroenterol Hepatol. 2006;21(7):1221.
7. Di Marco V, Lo Iacono O, Capra M, et al. Alpha interferon treatment of chronic hepatitis C in betathalassaemia. Gut. 1993;34(2 Suppl.):S142-S143. (Pubitemid 23156120)
8. Donohue SM, Wonke B, Hoffbrand AV, et al. Alpha interferon in the treatment of chronic hepatitis C infection in thalassaemia major. Br J Haematol. 1993;83(3):491-497.
9. Sievert W, Pianko S, Warner S, et al. Hepatic iron overload does not prevent a sustained virological response to interferon-alpha therapy: A long term follow-up study in hepatitis C-infected patients with beta thalassemia major. Am J Gastroenterol. 2002;97(4):982-987.
10. Hamidah A, Yong JF, Zulkifli HI, et al. Treatment of chronic hepatitis C virus infection with interferon alfa and ribavirin: Sustained response in two patients with transfusion dependent thalassaemia. Med J Malaysia. 2002;57(3):353-356.
11. Li CK, Chan PK, Ling SC, et al. Interferon and ribavirin as frontline treatment for chronic hepatitis C infection in thalassaemia major. Br J Haematol. 2002;117(3):755-758.
12. Sherker AH, Senosier M, Kermack D. Treatment of transfusion-dependent thalassemic patients infected with hepatitis C virus with interferon alpha-2b and ribavirin. Hepatology. 2003;37(1):223.
13. Telfer PT, Garson JA, Whitby K, et al. Combination therapy with interferon alpha and ribavirin for chronic hepatitis C virus infection in thalassaemic patients. Br J Haematol. 1997;98(4):850-855.
14. Inati A, Taher A, Ghorra S, et al. Efficacy and tolerability of peginterferon alpha-2a with or without ribavirin in thalassaemia major patients with chronic hepatitis C virus infection. Br J Haematol. 2005;130(4):644-646.
15. Ancel D, Amiot X, Chaslin-Ferbus D, et al. Treatment of chronic hepatitis C in sickle cell disease and thalassaemic patients with interferon and ribavirin. Eur J Gastroenterol Hepatol. 2009;21(7):726-729.